ARCHIVES

HER2+ Tumors Increase Risk Of Recurrence, Study Finds

This article is from The Cancer Letter archive.

Vol. 32 No. 11 | November 27, 2009

Download PDF Visit The Full Archive

Related Articles

NCI CTEP Approved Trials For the Month of January

January 31, 2014

Rejecting Data, Believers In PSA Screening Strengthen Guidelines, Launch Outreach

September 11, 2009

New Treatments And Quality of Life Study For Ovarian Cancer Described At SGO

March 26, 2004

RFAs Available.

July 4, 2003

FDA Approves Avastin For Recurrent NSCLC

October 27, 2006

Miami Core Grant Not Renewed, Status Threatened

September 21, 1990